We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Selecta

News List

3SBio Inc. received milestone payment of USD 4 million upon commencement of phase III clinical program of SEL-212 prnasia
November 24, 2020
Chinese leading biopharmaceutical company, 3SBio Inc., announced today that Selecta Biosciences, Inc., the Company's partner, has commenced the phase III clinical program of a combination therapy involving SEL-212 for the treatment of ...
Selecta lays off staff as R&D cash crunch looms fiercebiotech
January 07, 2019
Selecta Biosciences is laying off more than one-third of its workforce. The cuts come as Selecta seeks to eke out its cash reserves and advance a gout drug that disappointed investors in phase 2......